M

MaxCyte, Inc.

130 employees

MaxCyte specializes in cell modification technologies that enable the discovery, development, and manufacture of various classes.

Basic info

Industry

biotechnology research

Sectors

Immuno-oncology
Biotechnology
Cell Engineering
Gene Therapy
Stem Cell
Cancer
CARMA
Cell Therapy
Gene Editing
Cancer Research
NKcell
Immunotherapy
Life Sciences
Electroporation
Tcell
Transfection
MyExpertPlatform
Medical Device
Bispecifics
Vaccine Development
Innovation
Manufacturing
Protein Production

Date founded

1999

Funding rounds raised

Total raised

$11M

from 2 investors over 2 rounds

M

MaxCyte, Inc. raised $11M on March 24, 2004

Investors: Tall Oaks Capital and Intersouth Partners

FAQ